XML 36 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
In 2012, the Company’s Board adopted and shareholders approved the 2012 Incentive Plan. The 2012 Incentive Plan provided for a maximum of 8,700,000 shares of common stock in the aggregate that could be issued pursuant to options, restricted stock, stock appreciation rights, restricted stock units or other performance award grants.
In 2019, the Board adopted and shareholders approved the 2019 Incentive Plan. In 2022, the Board adopted and shareholders approved the first amendment to the 2019 Long-Term Incentive Plan authorizing an additional 3,725,000 shares of common stock for issuance to employees, directors, contractors or advisors of the Company. As of December 31, 2023, the 2019 Incentive Plan provided for a maximum of 4,488,901 shares of common stock in the aggregate that may be issued pursuant to grants of options, restricted stock, stock appreciation rights, restricted stock units or other performance award grants. The persons eligible to receive awards under the 2019 Incentive Plan include employees, directors, contractors or advisors of the Company. The primary purpose of the 2019 Incentive Plan is to attract and retain key employees, directors, contractors or advisors of the Company. With the adoption of the 2019 Incentive Plan, the Company does not expect to make any future awards under the 2012 Incentive Plan, but the 2012 Incentive Plan will remain in place until all awards outstanding under that plan have been settled.
The 2012 Incentive Plan and 2019 Incentive Plan (collectively, the “LTIPs”) are administered by the independent members of the Board, who, upon recommendation of the Strategic Planning and Compensation Committee of the Board, determine the number of options, restricted shares or other awards to be granted, the effective dates, the terms of the grants and the vesting periods. The Company typically uses newly issued shares of common stock to satisfy option exercises or restricted share grants.
During the years ended December 31, 2023, 2022 and 2021, the Company granted both equity-based and liability-based awards under the 2019 Incentive Plan. The fair value of equity-based awards is fixed at the grant date, while the fair value of liability-based awards is remeasured at each reporting period.
In 2022, the Board adopted and shareholders approved an Employee Stock Purchase Plan (the “ESPP”), which authorizes a maximum of 4.0 million shares of common stock to be purchased. The purpose of the ESPP is to encourage and enable the Company’s eligible employees to acquire an interest in the Company through the ownership of common stock. At December 31, 2023, the Company had 3,934,015 remaining shares available for issuance under the ESPP.
Service-Based Restricted Stock, Restricted Stock Units and Common Stock
The Company has granted stock, restricted stock and restricted stock unit awards to employees, consultants, outside directors and advisors of the Company under the LTIPs. The stock and restricted stock are issued upon grant, with the restrictions, if any, being removed upon vesting. The equity-based restricted stock units are issued upon vesting, unless the recipient makes an election to defer issuance for a set term after vesting. Liability-based restricted stock units are settled in cash upon vesting. Restricted stock and restricted stock units granted in 2023, 2022 and 2021 were service-based awards, which will settle in cash or equity, and vest over a one-year to three-year period. Performance-based restricted stock units granted in 2023 and 2022 vest in an amount between zero and 200% of the target units granted based on the Company’s relative total shareholder return over the three-year periods ending December 31, 2025 and 2024, respectively, as compared to a designated peer group, and will be settled in equity.
Equity-Based
A summary of the non-vested equity-based restricted stock and restricted stock units as of December 31, 2023 is presented below (in thousands, except fair value).
 Restricted StockRestricted Stock Units
Service Based Service Based Performance Based
Non-vested restricted stock and
restricted stock units
SharesWeighted
average
fair
value
SharesWeighted
average
fair
value
SharesWeighted
average
fair
value
Non-vested at December 31, 2022
658 $24.59 16 $66.16 596 $56.31 
Granted277 $53.53 24 $51.50 144 $87.39 
Vested(1)
(290)$19.90 (16)$66.16 (281)$50.53 
Forfeited(49)$47.50 — $— (103)$54.81 
Non-vested at December 31, 2023
596 $47.31 24 $51.50 356 $73.82 
__________________    
(1)On December 31, 2023, 280,500 of the performance-based awards that were granted in 2021 vested. The vested units earned 178% for each vested award representing 499,290 aggregate shares of common stock, which were issued on December 31, 2023.
Liability-Based
A summary of the non-vested liability-based restricted stock units as of December 31, 2023 is presented below (in thousands).
Non-vested restricted stock unitsShares
Non-vested at December 31, 2022
722 
Granted229 
Vested(379)
Forfeited(107)
Non-vested at December 31, 2023
465 
During the years ended December 31, 2023, 2022 and 2021, the Company settled 378,852, 587,251 and 487,252 liability-based awards, respectively, for $20.5 million, $30.8 million and $12.4 million in cash, respectively.
At December 31, 2023, the aggregate intrinsic value for the restricted stock and restricted stock units outstanding was $82.8 million, of which $26.7 million is expected to be settled in cash as calculated based on the maximum number of shares of restricted stock units vesting, based on the closing price of Matador’s common stock on the appropriate date under the LTIPs.
At December 31, 2023, the total remaining unrecognized compensation expense related to unvested restricted stock and restricted stock units was approximately $49.2 million, of which $17.6 million is expected to be settled in cash, based on the closing price of Matador’s common stock on the appropriate date under the LTIPs. The weighted average remaining requisite service period (vesting period) of all non-vested restricted stock and restricted stock units was 1.7 years.
The fair value of restricted stock and restricted stock units vested during 2023, 2022 and 2021 was $64.8 million, $99.6 million and $51.9 million, respectively.
Summary
During the years ended December 31, 2023, 2022 and 2021, the total expense attributable to restricted stock and restricted stock units was $33.0 million, $51.6 million and $36.3 million, respectively. During the year ended December 31, 2023, the Company did not recognize expense attributable to stock options. During the years ended December 31, 2022 and 2021, the total expense attributable to stock options was $0.5 million and $1.0 million, respectively. During the years ended December 31, 2023, 2022 and 2021, the Company capitalized $7.4 million, $5.0 million and $7.2 million, respectively, related to stock-based compensation and expensed the remaining $25.6 million, $47.1 million and $30.0 million, respectively.
The total tax benefit recognized for all stock-based compensation was $7.0 million, $11.0 million and $7.9 million for the years ended December 31, 2023, 2022 and 2021, respectively.